The True External Pulsatile Artificial Heart
In the face of stagnant survival rates with standard ECMO devices—oscillating between 35% and 50% for the past two decades—CardioDyn provides a concrete response to one of the greatest challenges in intensive care: improving survival and eligibility for patients with acute heart failure.
Unlike continuous-flow ECMO, it delivers a physiological pulse wave synchronized with the ECG in cardiac counterpulsation, ensuring both improved coronary and distal perfusion while enabling cyclic unloading of the cardiac chambers.
Less deleterious, simpler to implant, and fully self-regulated, it allows for earlier intervention, even outside highly specialized centers.
CardioDyn thus broadens access to life-saving support, offering safer, better-tolerated, and more effective care. By redefining the standards of temporary cardiac assistance, it paves the way for more accessible and higher-performing medicine.
The CardioDyn Advantage: Breakthrough Technology and Concept for Temporary Cardiac Support
CardioDyn technology generates a pressure-regulated pulse wave, controlled by a real-time computer.
It intervenes at the optimal moment of each cardiac cycle thanks to precise synchronization with ECG signals.
Equipped with pressure sensors, it adjusts its assistance with each beat according to the patient's needs.
With each cycle, CardioDyn delivers the necessary additional pressure and blood flow.
This approach ensures hemodynamic support that is both physiological and optimized.
CardioDyn: Revolutionizing the Treatment of Heart Disease
CardioDyn's advanced and less harmful physiological design promotes rapid clinical adoption, setting a new benchmark for temporary mechanical cardiac support. Its fully automated regulation makes it the tool of choice for Mobile Cardiac Support Units (MCSUs), enabling easy pre-hospital implantation as soon as the patient is taken into care. Thanks to its pulsatility and synchronization, this unique capability positions CardioDyn as an essential pillar of the future of cardiac support. More physiological, self-regulating, and easy to install, it offers a safer and better-tolerated solution for patients.